Clinical Trial Update: Study of CG0070 After Transurethral Resection in Patients With IR NMIBC [Phase 1]

View source ↗

Summary

Clinical trial update for CG0070 in patients with non-muscle invasive bladder cancer following transurethral resection; Phase 1 study is currently ACTIVE_NOT_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• CG0070

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Non-muscle Invasive Bladder Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING